Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)
ConditionUveal Melanoma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInstitut Curie
About this trial
Biomarkers search for early diagnosis of liver metastases in patients with uveal melanoma who benefit from a follow-up tailored to their personalized risk of relapse.
Eligibility criteria
Qualifiers
Patient aged of 18 years or more.
T2b/c/d ou ≥ T3,
or chromosom 3 or chromosom 8 abnormality by CGH array.
Completion of treatment of the primary tumor ≤ 2 months.
Disqualifiers
Patient without french social insurance.
Any social, medical or psychological condition making the research process impossible.
Trial design
Treatments tested in this trial
- Blood test
Treatment groups
700 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov